We hypothesized that downregulation of enzymes involved in DNA synthesis as a consequence of E2F inhibition, particularly TS and TK, would sensitize tumor cells to combinations of the D-Arg PEP with agents targeting these enzymes, e.g., pemetrexed, which targets TS (Figure 1). The gene discussed is TKT; the disease is neoplasm.